Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Apr;50(4):838–848. doi: 10.1172/JCI106555

C1r, subunit of the first complement component: purification, properties, and assay based on its linking role

Maria M E De Bracco 1, R M Stroud 1
PMCID: PMC291998  PMID: 4100685

Abstract

A method to obtain C1r, a subunit of the first complement component, in a highly purified state has been described for the first time. The stepwise method starts with a neutral euglobulin precipitation, after diethylaminoethyl- and carboxymethyl-cellulose chromatography and a final preparative polyacrylamide electrophoresis step. Such C1r preparations are devoid of C1q and C1s activities and show only one protein band on analytic polyacrylamide electrophoresis. Rabbits injected with this preparation produced antisera showing only one precipitation band. The stability of C1r activity was determined under different conditions, and C1r was found to be labile at 37°C, pH 7-8 and low ionic strength.

The electrophoretic mobility of purified C1r is that of a β-globulin on disc acrylamide electrophoresis and on agarose electrophoresis at pH 8.6. Its molecular weight as estimated by sephadex chromatography is 168,100.

A sensitive hemolytic assay based on the property of C1r to link C1s to C1q and thereby to generate macromolecular C[unk]1 is described. The number of C[unk]1 molecules generated is stoichiometrically related to the concentration of C1r for a fixed C1q and C1s concentration provided that the titration is carried out below the plateau zone. Macromolecular C1 can be separated from free C1s as the former is cell bound.

This method of purification and assay should allow the development of monospecific antisera and further chemical study of C1r.

Full text

PDF
838

Images in this article

841Image
on p.841
842Image
on p.842
843Image
on p.843

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J. 1964 May;91(2):222–233. doi: 10.1042/bj0910222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BECKER E. L. Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate. J Immunol. 1956 Dec;77(6):462–468. [PubMed] [Google Scholar]
  3. BORSOS T., RAPP H. J. CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS. J Immunol. 1963 Dec;91:851–858. [PubMed] [Google Scholar]
  4. Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969 May 1;129(5):1109–1130. doi: 10.1084/jem.129.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  6. Donaldson V. H. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro. J Exp Med. 1968 Mar 1;127(3):411–429. doi: 10.1084/jem.127.3.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Donaldson V. H., Ratnoff O. D., Dias Da Silva W., Rosen F. S. Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest. 1969 Apr;48(4):642–653. doi: 10.1172/JCI106022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gigli I., Austen K. F. Fluid phase destruction of C2hu by C1hu. II. Unmasking by C4ihu of C1hu specificity for C2hu. J Exp Med. 1969 Oct 1;130(4):833–846. doi: 10.1084/jem.130.4.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hanauer L. B., Christian C. L. Clinical studies of hemolytic complement and the 11S component. Am J Med. 1967 Jun;42(6):882–890. doi: 10.1016/0002-9343(67)90069-1. [DOI] [PubMed] [Google Scholar]
  10. Kohler P. F., Müller-Eberhard H. J. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. J Immunol. 1967 Dec;99(6):1211–1216. [PubMed] [Google Scholar]
  11. LEPOW I. H., NAFF G. B., TODD E. W., PENSKY J., HINZ C. F. Chromatographic resolution of the first component of human complement into three activities. J Exp Med. 1963 Jun 1;117:983–1008. doi: 10.1084/jem.117.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LEPOW I. H., PILLEMER L., RATNOFF O. D. The influence of calcium ions on the inactivation of human complement and its components by plasmin. J Exp Med. 1953 Sep;98(3):277–289. doi: 10.1084/jem.98.3.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LEPOW I. H., WURZ L., RATNOFF O. D., PILLEMER L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++. J Immunol. 1954 Sep;73(3):146–158. [PubMed] [Google Scholar]
  14. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  16. NAFF G. B., PENSKY J., LEPOW I. H. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1964 Apr 1;119:593–613. doi: 10.1084/jem.119.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Naff G. B., Ratnoff O. S. The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r. J Exp Med. 1968 Oct 1;128(4):571–593. doi: 10.1084/jem.128.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nagaki K., Stroud R. M. A method for preparing monospecific antisera to Cl esterase (Cls): microheterogeneity of purified Cls. J Immunol. 1970 Jul;105(1):162–169. [PubMed] [Google Scholar]
  19. Nagaki K., Stroud R. M. Specific antisera to C1s: detection of different electrophoretic species of C1s. J Immunol. 1969 Jul;103(1):141–145. [PubMed] [Google Scholar]
  20. Nagaki K., Stroud R. M. The relationship of the hemolytic activity of active C'1s to its TAMe esterase action: a new method of purification and assay. J Immunol. 1969 Feb;102(2):421–430. [PubMed] [Google Scholar]
  21. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  22. PENSKY J., LEVY L. R., LEPOW I. H. Partial purification of a serum inhibitor of C'1-esterase. J Biol Chem. 1961 Jun;236:1674–1679. [PubMed] [Google Scholar]
  23. Pickering R. J., Naff G. B., Stroud R. M., Good R. A., Gewurz H. Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1. J Exp Med. 1970 Apr 1;131(4):803–815. doi: 10.1084/jem.131.4.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ratnoff O. D., Naff G. B. The conversion of C'IS to C'1 esterase by plasmin and trypsin. J Exp Med. 1967 Feb 1;125(2):337–358. doi: 10.1084/jem.125.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ratnoff O. D., Naff G. B. The role of c'1q, cations, and ionic strength in the formation of C'1 esterase. J Lab Clin Med. 1969 Sep;74(3):380–388. [PubMed] [Google Scholar]
  26. Ratnoff O. D., Pensky J., Ogston D., Naff G. B. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med. 1969 Feb 1;129(2):315–331. doi: 10.1084/jem.129.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stroud R. M., Nagaki K., Pickering R. J., Gewurz H., Good R. A., Cooper M. D. Sub-units of the first complement component in immunologic deficiency syndromes: independence of Cls and Clq. Clin Exp Immunol. 1970 Aug;7(2):133–137. [PMC free article] [PubMed] [Google Scholar]
  28. Tamura N., Nelson R. A., Jr The purification and reactivity of the first component of complement from guinea pig, human and canine sera. J Immunol. 1968 Dec;101(6):1333–1345. [PubMed] [Google Scholar]
  29. van Oss C. J., Bronson P. M. Immunorheophoresis. Immunochemistry. 1969 Nov;6(6):775–778. doi: 10.1016/0019-2791(69)90283-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES